CLASS II ONGOING Device recall · Reported 17 Jan 2024 · FDA Enforcement Report

Mynxgrip 5F recalled by Cordis US

Cordis US is recalling Mynxgrip 5F, distributed in 7 states. The recall was initiated on 28 Nov 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 10862028000403, Lot numbers: F2322902
Quantity recalled50 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0674-2024
FDA event ID
93617
Recalling firm
Cordis US, Miami Lakes, FL
Classification
Class II
Status
Ongoing
Recall initiated
28 Nov 2023
FDA classified
5 Jan 2024
Reported
17 Jan 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

28 Nov 2023Recall initiated by company
5 Jan 2024Classified by FDA+38 days
17 Jan 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Cordis became aware that the label for the carton box containing 10 units is incorrect for some boxes of two lots of MynxGrip. The carton box from lot F2322902 (Item MX5021, MynxGrip 5F) as labeled as lot F2322903 (MX6721, MynxGrip 6/7F) and product from lot F2322903 (MX6721, MynxGrip 6/7F) was labeled as F2322902 (Item MX5021, MynxGrip 5F). The primary label on individual devices is correct.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

MYNXGRIP 5F, REF MX5021, Vascular Closure Device (VCD). Used to seal femoral arterial and femoral venous access sites.

Where it was distributed

US: NC, WV, TN, MS, MI, OH, CA

CaliforniaMichiganMississippiNorth CarolinaOhioTennesseeWest Virginia

Questions about this recall

Why was it recalled?

Cordis became aware that the label for the carton box containing 10 units is incorrect for some boxes of two lots of MynxGrip. The carton box from lot F2322902 (Item MX5021, MynxGrip 5F) as labeled as lot F2322903 (MX6721, MynxGrip 6/7F) and product from lot F2322903 (MX6721, MynxGrip 6/7F) was labeled as F2322902 (Item MX5021, MynxGrip 5F). The primary label on individual devices is correct.

Which lots are affected?

UDI/DI 10862028000403, Lot numbers: F2322902

Where was it sold?

US: NC, WV, TN, MS, MI, OH, CA

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 93617
ReportedClassRecallCompanyReasonWhere
CLASS IIMynxgrip 6f/7f recalled by Cordis USCordis USPackaging Defects7 states

More recalls from Cordis US

All 22

Other Heart & Vascular Devices recalls

All 6,220